Zybio has showcased its latest in-vitro diagnostic inventions at AACC (American Association for Clinical Chemistry), the world’s largest global laboratory medicine exposition, which kicked off at McCormick Place, Chicago,Illinois on July 31-August 2, 2018.
Over 10 years’ focused on IVD area, Zybio has implemented high standard in all aspects in terms of research & development, production, marketing, sales and technical services to satisfy the needs of our users.
Our self-developed Hematology Analyzer Z5 and Chemistry Analyzer EXC200 as the new products drew widespread attention.
Z5 is a 5 diff-hematology analyzer with 29 parameters, 2 scatter-grams and 2 histograms, aimed at satisfying all customers’ needs. Z5 is designed with highly integrated electronic broads, optional liquid handling system and uncompromising performance.
EXC200, an Automated-Chemistry Analyzer, is an optimal bench-top solution for clinical chemistry with maximum 240T/H, aimed at serving the small hospitals or labs. EXC200 is designed with excellent performance, HD screen, high quality imported components, and low cross contamination which helps it become a more stable system, low water consumption makes it cost effective.
We believe that Z5 and EXC200 can beyond your expectation in your hospitals or labs. Beyond Z5 and EXC200, our self-developed Quantitative Immunoassay Analyzer Q7, Hematology Analyzer Z3 along with major chemistry reagents were demonstrated during the great exposition.
With the vision to bring better healthcare for all, zybio will continue its commitment to provide high-quality, customer-centric technological innovations and services to the medical communities worldwide. We warmly welcome whoever shares the same vision to collaborate at Booth: 358.